04 Aug, 2021 RNAi Roundtable: Givosiran, for the Treatment of Acute Hepatic Porphyria
On August 4, 2021, we hosted an online RNAi Roundtable to review the progress with givosiran, for the treatment of acute hepatic porphyria.
Akin Akinc, Ph.D.
Vice President & General Manager, Givosiran
Marianne Sweetser, M.D., Ph.D.
Senior Distinguished Fellow, Clinical Development
Laurent Placidi, Ph.D., PharmD.
Senior Director, Global Marketing, Givosiran